Morgan Stanley Reiterates Overweight Rating on Eli Lilly (LLY) Following Healthcare Conference, Fireside Chat
Tweet Send to a Friend
Morgan Stanley analyst Terrance Flynn reiterated an Overweight rating and $412.00 price target on Eli Lilly (NYSE: LLY) after hosting ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
